- Home
- SO vs GSK Comparison
SO vs GSK Comparison
Compare SO & GSK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | SO | GSK |
|---|---|---|
| Founded | 1945 | 1715 |
| Country | United States | United Kingdom |
| Employees | N/A | N/A |
| Industry | Power Generation | Biotechnology: Pharmaceutical Preparations |
| Sector | Utilities | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 101.3B | 96.1B |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | SO | GSK |
|---|---|---|
| Price | $98.07 | $53.47 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 17 | 2 |
| Target Price | ★ $98.78 | N/A |
| AVG Volume (30 Days) | ★ 6.6M | 4.9M |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | 3.02% | ★ 3.23% |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $8.18 | $6.81 |
| Revenue Next Year | $5.61 | $4.74 |
| P/E Ratio | ★ $22.63 | $32.75 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $83.80 | $32.38 |
| 52 Week High | $100.84 | $61.70 |
Technical Indicators
Market Signals| Indicator | SO | GSK |
|---|---|---|
| Relative Strength Index (RSI) | 65.39 | 37.71 |
| Support Level | $90.46 | $47.89 |
| Resistance Level | $100.84 | $60.37 |
| Average True Range (ATR) | 1.52 | 0.93 |
| MACD | -0.11 | -0.78 |
| Stochastic Oscillator | 79.82 | 1.31 |
Price Performance
Historical ComparisonAbout SO Southern Company (The)
Southern is one of the largest utilities in the US. The company serves 9 million customers with vertically integrated electric utilities in three states and natural gas distribution utilities in four states. It owns 44 gigawatts of rate-regulated generating capacity, primarily for serving customers in Georgia, Alabama, and Mississippi. Subsidiary Southern Power owns 13 gigawatts of natural gas generation and renewable energy across the US and sells the electricity primarily under long-term contracts.
About GSK GSK plc (Each representing two)
In the pharmaceutical industry, GSK ranks as one of the largest firms by total sales. The company wields its might across several therapeutic classes, including respiratory, antiviral, and vaccines, and has been growing its presence in oncology and immunology, as well. GSK uses joint ventures to gain additional scale in certain markets like HIV.